EIKN · Categories · Form 4

EIKN - SEC Form 4 insider transactions

Eikon Therapeutics Inc. (EIKN) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for EIKN

• 53d
  SEC Form 4 filed by Chief Operating Officer Klobuchar Michael A

  4 - Eikon Therapeutics, Inc. (0001861123) (Issuer)
• 53d
  SEC Form 4 filed by Director Huffines Robert Luther

  4 - Eikon Therapeutics, Inc. (0001861123) (Issuer)
• 53d
  SEC Form 4 filed by Director Frazier Kenneth C

  4 - Eikon Therapeutics, Inc. (0001861123) (Issuer)
• 53d
  SEC Form 4 filed by Officer Perlmutter Roger M

  4 - Eikon Therapeutics, Inc. (0001861123) (Issuer)
• 53d
  SEC Form 4 filed by Officer Thorner Benjamin Bruno

  4 - Eikon Therapeutics, Inc. (0001861123) (Issuer)
• 53d
  SEC Form 4 filed by Chief Medical Officer Baynes Roy D.

  4 - Eikon Therapeutics, Inc. (0001861123) (Issuer)
• 53d
  SEC Form 4 filed by Chief Financial Officer Bowie Alfred Lloyd Jr.

  4 - Eikon Therapeutics, Inc. (0001861123) (Issuer)
• 75d
  Officer Perlmutter Roger M converted options into 284,857 shares (SEC Form 4)

  4 - Eikon Therapeutics, Inc. (0001861123) (Issuer)

Other EIKN categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends